NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

EHA 2025
Dec 31, 2025, 08:40 | Blog
Ending 2025 Together: Building the Future of Hemostasis Today - and It’s Just the Beginning
From the Start: May 2025 to Today From the very beginning, Hemostasis Today was founded…
Oct 5, 2025, 07:56 | Insight
Rucha Patil: I Had An Opportunity to Deliver a Lecture on A Topic Close to My Heart at EHA 2025
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared…
Sep 30, 2025, 15:47 | Organizations
Rucha Patil: Honored to Inaugurate the MHG Mid-Term Conference 2025 and Essence of EHA 2025
Rucha Patil, Scientist, Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a…
Jun 23, 2025, 11:26 | Insight
VEXAS Syndrome Research by Pierre Sujobert Awarded by HemaSphere
HemaSphere Journal, recently posted on X: “ At EHA2025, HemaSphere was honored to award authors…
Jun 18, 2025, 10:50 | Organizations
EHA 2025 Was a Great Success - VJHemOnc
The Video Journal of Hematology & Hematological Oncology (VJHemOnc) shared a post on X: "EHA…
Jun 17, 2025, 17:07 | Voices
Mark Wildgust: Outstanding Results from the FLAIR Study Presented at EHA25
Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson…
Jun 17, 2025, 06:55 | Voices
Anna Sureda: Excellent EHA-EBMT Joint Session at EHA 2025 in Milan
Anna Sureda, Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme at the…
Jun 17, 2025, 03:17 | Voices
Carmelo Gurnari: What a Nice EHA 2025
Carmelo Gurnari, Hematologist/Oncologist and Researcher at the Cleveland Clinic, shared a post on X: “What…
Jun 16, 2025, 18:24 | Science
Talha Badar: TKI Selection Based on Mutation Profiles in CML at EHA 2025
Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X: "Emergence of ASXL1…
Jun 16, 2025, 16:24 | Science
Yelak Biru: Anito-Cel Drives Durable Responses in R/R Multiple Myeloma
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, posted on X: “Congratulations Dr.…
Jun 16, 2025, 15:00 | Voices
Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA 2025
Thomas Miller, Principal Investigator at Institut Paoli-Calmettes, shared a post on LinkedIn: "Unlocking Smarter BCL-2…
Jun 16, 2025, 02:06 | Insight
C. Ola Landgren: Presenting ADVANCE Trial Results in Multiple Myeloma at EHA25
C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center,…
Jun 16, 2025, 02:02 | Voices
Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health…
Jun 15, 2025, 11:17 | Insight
10 Posts Not to Miss from EHA 2025
The European Hematology Association (EHA) Congress 2025 is officially underway in Milan. From June 12…
Jun 15, 2025, 09:34 | Insight
7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann
The European Hematology Association (EHA) 2025 events bring together global experts to explore the latest…
Jun 13, 2025, 23:21 | Voices
Paul J Bröckelmann Shares The Lancet Haematology Commission Update on Adverse Events at EHA 2025
The Lancet Haematology shared a post on X: "Today at EHA2025 Dr Paul J Bröckelmann…
Jun 12, 2025, 06:11 | Insight
EHA 2025: A Gateway to Publishing Excellence with The Lancet Haematology
The Lancet Haematology shares on X. "On your way to EHA2025 Congress in Milan? Cheryl…
All: 17 Posts: 1 - 100
NewsFeed